Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2025 14:05 ET | Source: Cosmos Health Inc.

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

CHICAGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it...
October 03, 2025 15:56 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

CHICAGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its...
September 29, 2025 08:00 ET | Source: Cosmos Health Inc.

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Expansion & AI R&D
September 25, 2025 08:00 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health expands order book with contract to manufacture 3 million units of MYCOFAGYL® pessaries, broadening its portfolio into gynecology.
September 11, 2025 08:00 ET | Source: Cosmos Health Inc.

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health signs distribution deal with Scientific Pharmacy to launch Sky Premium Life in Oman, including an initial order of 42,000 supplement units.
August 18, 2025 12:45 ET | Source: Cosmos Health Inc.

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health reported Q2 2025 results with 11.7% revenue growth and H1 gross profit up 53% to $3.21M, remaining on track with profitability targets
August 12, 2025 09:50 ET | Source: Cosmos Health Inc.

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Makes Initial $1M Ethereum (ETH) Purchase Under Digital Asset Treasury Strategy
August 06, 2025 09:20 ET | Source: Cosmos Health Inc.

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health secures financing of up to $300 million to develop an ETH-backed treasury, with remaining proceeds for growth and general working capital
June 24, 2025 10:55 ET | Source: Cosmos Health Inc.

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Cosmos Health expands into the U.S. with local manufacturing to reduce tariff risks, partnering with New Jersey-based DolCas Biotech for production.
May 15, 2025 14:30 ET | Source: Cosmos Health Inc.

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven.